BALDINI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 18.136
AS - Asia 9.594
EU - Europa 6.583
SA - Sud America 1.628
AF - Africa 569
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 12
Totale 36.582
Nazione #
US - Stati Uniti d'America 17.558
SG - Singapore 2.974
CN - Cina 2.732
IT - Italia 1.730
HK - Hong Kong 1.582
BR - Brasile 1.305
SE - Svezia 1.025
VN - Vietnam 1.017
DE - Germania 809
BG - Bulgaria 595
GB - Regno Unito 485
CA - Canada 416
FR - Francia 402
FI - Finlandia 365
RU - Federazione Russa 286
TR - Turchia 273
IN - India 236
NL - Olanda 202
JP - Giappone 189
CI - Costa d'Avorio 155
UA - Ucraina 136
NG - Nigeria 106
AT - Austria 103
ES - Italia 98
MX - Messico 93
BD - Bangladesh 89
SN - Senegal 87
AR - Argentina 86
KR - Corea 77
IQ - Iraq 67
PL - Polonia 59
AU - Australia 55
CH - Svizzera 55
BE - Belgio 52
MA - Marocco 51
ZA - Sudafrica 49
EC - Ecuador 48
ID - Indonesia 47
CO - Colombia 44
CL - Cile 40
UZ - Uzbekistan 36
VE - Venezuela 34
PK - Pakistan 32
IE - Irlanda 31
SA - Arabia Saudita 31
KE - Kenya 28
LT - Lituania 23
PY - Paraguay 23
EG - Egitto 22
PH - Filippine 22
MY - Malesia 20
PE - Perù 20
RO - Romania 19
DZ - Algeria 18
TW - Taiwan 18
GR - Grecia 17
JO - Giordania 17
IL - Israele 15
UY - Uruguay 15
CR - Costa Rica 13
LB - Libano 13
PT - Portogallo 13
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
BO - Bolivia 10
DK - Danimarca 10
ET - Etiopia 10
JM - Giamaica 10
NP - Nepal 10
PS - Palestinian Territory 9
AL - Albania 8
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
EU - Europa 8
IR - Iran 8
AM - Armenia 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NO - Norvegia 7
TH - Thailandia 7
AO - Angola 6
BJ - Benin 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
NI - Nicaragua 6
PA - Panama 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
BY - Bielorussia 5
HN - Honduras 5
HR - Croazia 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
OM - Oman 5
GT - Guatemala 4
LU - Lussemburgo 4
MD - Moldavia 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 36.516
Città #
Ashburn 1.851
Singapore 1.641
Woodbridge 1.634
Hong Kong 1.545
Dallas 1.272
Ann Arbor 1.127
San Jose 1.119
Houston 1.049
Santa Clara 1.002
Fairfield 992
Chandler 897
Shanghai 653
Beijing 618
Sofia 591
New York 480
Seattle 444
Wilmington 380
Boardman 372
Milan 359
Cambridge 333
Los Angeles 286
Princeton 278
Ho Chi Minh City 275
Munich 271
Ottawa 268
Lawrence 234
Medford 218
Lauterbourg 189
Hanoi 183
Council Bluffs 180
Nanjing 167
Abidjan 155
Serra 154
Florence 146
Tokyo 146
Jacksonville 144
Des Moines 140
Hefei 130
London 126
Frankfurt am Main 122
Helsinki 122
São Paulo 119
Izmir 108
Istanbul 107
Lagos 105
Dearborn 102
Dong Ket 96
Redondo Beach 92
Dakar 87
Rome 87
Bremen 85
Buffalo 80
Vienna 77
Turku 74
San Diego 71
Pisa 67
Pune 59
Redwood City 57
Seoul 57
Ogden 55
Amsterdam 54
Nanchang 50
Nuremberg 47
Orem 45
Chicago 44
Fuzhou 44
Warsaw 43
Falls Church 42
Kunming 42
Düsseldorf 41
Lancaster 41
Shenyang 40
Guangzhou 38
Rio de Janeiro 38
Bern 37
Belo Horizonte 36
Brussels 35
Paris 35
Hebei 34
Marseille 34
Tashkent 34
Boulder 33
Montreal 33
Atlanta 32
Da Nang 32
Jüchen 31
Changsha 30
Dublin 30
Chennai 29
Denver 29
Phoenix 29
Haiphong 28
San Francisco 28
Jiaxing 26
Manchester 26
Toronto 26
Boston 25
Brooklyn 25
Livorno 25
Baghdad 24
Totale 25.273
Nome #
Sjögren syndrome 1.406
Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: Review of the literature and a cross-sectional prospective experience 319
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 235
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 230
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 230
Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study 220
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 211
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 204
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 204
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 202
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 199
Classification criteria 197
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 196
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 194
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 189
Skin manifestations and sjögren’s syndrome 189
Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature 188
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 185
Proteomics approach as a tool for salivary fingerprint characterization able to discriminate different Sjögren’s syndrome phenotype. 185
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 185
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 184
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 184
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 183
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 183
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 180
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 178
Skin manifestations and cryoglobulinemia 176
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 175
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 175
Anti-Sm and anti-RNP antibodies 175
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 173
Biomarkers for Sjögren's syndrome 172
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 171
Ultra-High Frequency Ultrasound, A Promising Diagnostic Technique: Review of the Literature and Single-Center Experience 171
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 171
Undifferentiated connective tissue diseases (UCTD) 169
Classification criteria for Sjogren's syndrome: A critical review. 163
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 162
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 161
The association of Sjögren syndrome and autoimmune thyroid disorders 161
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 160
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients 160
Primary Sjogren's Syndrome: clinical and serological feature of a single centre [Sindrome di Sjogren primitiva: Descrizione clinica e sierologica di una casistica monocentrica] 157
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 157
Classification criteria in Sjögren’s syndrome 157
Mucocutaneous manifestations of Sjögren's Syndrome 156
Clinical manifestations and treatment of Churg-Strauss syndrome 155
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. 155
Myeloid neoplasms and autoimmune diseases: markers of association 155
Salivary histidine-rich glycoprotein: a novel putative biomarker for autoimmune disease. 154
Classification criteria for Sjogren's syndrome: A critical review. 153
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 152
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 152
Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab 151
Treatment of chronic hepatitis C infection with cryoglobulinemia. 151
Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? 150
Proteomic analysis of the saliva: A clue for understanding primary from secondary Sjogren's syndrome? 150
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 149
COVID-19: the new challenge for rheumatologists 149
Ultra-High Frequency Ultrasound (Uhfus) Applications in Sjogren Syndrome: Narrative Review and Current Concepts 147
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 146
Sjögren's syndrome: state of the art on clinical practice guidelines 146
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 146
Salivary Cystatin C and the imbalance between cysteine proteases and their inhibitors in Churg Strauss Syndrome. 145
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 145
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 143
Patterns of inflammation and dysfunction in pSS: identification of proteomic salivary biomarkers correlated with different disease phenotypes. 143
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome A consensus and data-driven methodology involving three international patient cohorts 143
The economic impact of gout: a systematic literature review. 142
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. 142
Proteomic diagnosis of Sjögren's syndrome 142
Artrite reumatoide e analisi proteomica della saliva 141
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 141
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study 140
Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome 140
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 140
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 140
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? 140
Analysis of the evolution of UCTD to defined CTD after a long-term follow-up. 139
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. 139
Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome 138
Aderenza allo screening per il cancro della cervice uterina in una coorte italiana di donne affette da LES [Adherence to cervical cancer screening in an Italian SLE cohort] 138
One year in review 2019: Sjögren’s syndrome 138
The CoV-2 outbreak: how hematologists could help to fight Covid-19 138
A Clinical prediction rule for lymphoma development in primary and secondary Sjogren’s syndrome. 137
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 137
COVID-19: the new challenge for rheumatologists. First update 137
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 137
Cryoglobulinemic vasculitis: a 2023 update 137
Primary-Sjögren's-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies. 136
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 136
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis 135
Chronic skin lichenification as unusual presentation of eosinophilic granulomatosis with polyangitis: case report and literature review 135
One year in review 2018: Sjögren's syndrome 135
Emerging trends in Sjögren's syndrome: basic and translational research. 134
Evoluzione verso connettiviti definite in una popolazione di pazienti affetti da “early undifferentiated connective tissue disease” [Analysis of the evolution to defined connective tissue diseases of patients with early undifferentiated connective tissue diseases (UCTD)] 133
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis 132
Detection of potential markers of primary fibromyalgia syndrome in human saliva 132
Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren's Syndrome and Overlapping Disorders. 131
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 131
Totale 17.455
Categoria #
all - tutte 109.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 0 0 0 0 0 0 0 0 0 338
2021/20222.647 47 181 39 170 481 380 98 137 137 99 161 717
2022/20233.435 440 430 248 288 408 380 43 237 580 50 265 66
2023/20242.607 240 241 280 178 387 507 140 72 54 74 131 303
2024/20258.298 74 322 120 405 701 1.001 801 470 808 1.056 962 1.578
2025/202610.441 693 1.279 1.423 886 1.141 874 1.541 523 586 909 405 181
Totale 37.514